Other · developed by Mannkind
Technosphere Inhalation Powder is an inhaled powder product. It was studied in patients with diabetes mellitus and kidney disease (nephropathy).
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00626249 | Phase 1 | Mild Nephropathy | Completed | MNKD |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Diabetes MellitusMild NephropathyModerate Nephropathy
Updated Oct 18, 2026. Something wrong or missing? Report it on the MNKD page.
See MNKD's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
MNKD catalysts and pipeline →